株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

ドラッグデリバリ用輸液システムの世界市場:医療機器のパイプライン評価

Infusion Systems - Medical Devices Pipeline Assessment, 2018

発行 GlobalData 商品コード 363396
出版日 ページ情報 英文 341 Pages
即納可能
価格
本日の銀行送金レート: 1USD=110.35円で換算しております。
Back to Top
ドラッグデリバリ用輸液システムの世界市場:医療機器のパイプライン評価 Infusion Systems - Medical Devices Pipeline Assessment, 2018
出版日: 2018年04月01日 ページ情報: 英文 341 Pages
概要

当レポートでは、世界のドラッグデリバリ (薬剤送達) 用輸液装置の市場における、主要なパイプライン製品とその治験の進行状況について調査すると共に、製品の機能・特性の比較分析 (治験の進行段階別) や、主要企業のプロファイルおよび代表的製品、昨今の市場動静 (業績報告・資本取引動向など) といった情報を取りまとめてお届けいたします。

第1章 目次

第2章 イントロダクション

  • ドラッグデリバリ用輸液システムの概要

第3章 治験中の製品

  • パイプライン製品:治験段階別
  • パイプライン製品:分野別
  • パイプライン製品:地域別
  • パイプライン製品:規制経路別
  • パイプライン製品:推定認証時期別
  • パイプライン製品:現在進行中の治験

第4章 治験中のパイプライン製品:企業別

  • ドラッグデリバリ用輸液システムの企業:治験段階別のパイプライン製品
  • ドラッグデリバリ用輸液システム:治験段階別のパイプライン製品

第5章 ドラッグデリバリ用輸液システム市場:企業・製品の概要

  • 410 Medical Innovation, LLC
    • パイプライン製品および進行中の治験の概要
  • Acuros GmbH
  • AktiVax Inc.
  • Alnylam Pharmaceuticals, Inc.
  • Anesthesia Safety Products, LLC
  • AngioDynamics, Inc.
  • Automedics Medical Systems
  • Baxter International Inc.
  • BioCardia, Inc.
  • Debiotech S.A.
  • Delpor, Inc.
  • Edwards Lifesciences Corporation
  • Eksigent Technologies, LLC
  • Eli Lilly and Company
  • Flowonix Medical, Inc.
  • FluidSynchrony, LLC
  • Fluonic, Inc. Company
  • Fresenius Kidney Care
  • Imagnus Biomedical Inc.
  • Innovfusion Pte. Ltd.
  • Intarcia Therapeutics, Inc.
  • IRadimed Corporation
  • Ivenix, Inc.
  • LifeMedix, LLC
  • Lynntech, Inc.
  • Medallion Therapeutics, Inc.
  • MedPrime Technologies Pvt. Ltd.
  • Mercator MedSystems, Inc.
  • Nano Precision Medical
  • NexGen Medical Systems, Inc.
  • ニプロ
  • Owen Mumford Limited
  • Pavmed Inc
  • PRO-IV Medical Ltd.
  • Ratio, Inc.
  • Rice University
  • SteadyMed Therapeutics, Inc.
  • StnDrd Infusion
  • Tel Aviv University
  • テルモ
  • ToucheMedical Ltd.
  • Unilife Corporation
  • University of Minnesota
  • University of Southern California

第6章 ドラッグデリバリ用輸液システム市場:昨今の動向 (全72件)

第7章 付録

図表一覧

目次
Product Code: GDME0527EPD

GlobalData's Medical Devices sector report, "Infusion Systems - Medical Devices Pipeline Assessment, 2018" provides an overview of Infusion Systems currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Infusion Systems pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Infusion Systems under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Infusion Systems and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Infusion Systems under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 10
  • 1.2 List of Figures 13

2 Introduction 14

  • 2.1 Infusion Systems Overview 14

3 Products under Development 16

  • 3.1 Infusion Systems - Pipeline Products by Stage of Development 16
  • 3.2 Infusion Systems - Pipeline Products by Segment 17
  • 3.3 Infusion Systems - Pipeline Products by Territory 18
  • 3.4 Infusion Systems - Pipeline Products by Regulatory Path 20
  • 3.5 Infusion Systems - Pipeline Products by Estimated Approval Date 21
  • 3.6 Infusion Systems - Ongoing Clinical Trials 22

4 Infusion Systems - Pipeline Products under Development by Companies 23

  • 4.1 Infusion Systems Companies - Pipeline Products by Stage of Development 23
  • 4.2 Infusion Systems - Pipeline Products by Stage of Development 25

5 Infusion Systems Companies and Product Overview 27

  • 5.1 410 Medical Inc Company Overview 27
    • 5.1.1 410 Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 27
  • 5.2 Adept Medical Ltd Company Overview 28
    • 5.2.1 Adept Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 28
  • 5.3 AngioDynamics Inc Company Overview 29
    • 5.3.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 29
  • 5.4 Arnali, LLC Company Overview 30
    • 5.4.1 Arnali, LLC Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.5 Baxter International Inc Company Overview 31
    • 5.5.1 Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview 31
  • 5.6 BioQ Pharma Inc Company Overview 32
    • 5.6.1 BioQ Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview 32
  • 5.7 Caesarea Medical Electronics Ltd Company Overview 37
    • 5.7.1 Caesarea Medical Electronics Ltd Pipeline Products & Ongoing Clinical Trials Overview 37
  • 5.8 ClearLine MD Company Overview 39
    • 5.8.1 ClearLine MD Pipeline Products & Ongoing Clinical Trials Overview 39
  • 5.9 ConvaTec Group Plc Company Overview 40
    • 5.9.1 ConvaTec Group Plc Pipeline Products & Ongoing Clinical Trials Overview 40
  • 5.10 Debiotech SA Company Overview 41
    • 5.10.1 Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview 41
  • 5.11 Edwards Lifesciences Corp Company Overview 42
    • 5.11.1 Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview 42
  • 5.12 Eksigent Technologies LLC Company Overview 43
    • 5.12.1 Eksigent Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 43
  • 5.13 Eli Lilly and Co Company Overview 45
    • 5.13.1 Eli Lilly and Co Pipeline Products & Ongoing Clinical Trials Overview 45
  • 5.14 EryDel SPA Company Overview 46
    • 5.14.1 EryDel SPA Pipeline Products & Ongoing Clinical Trials Overview 46
  • 5.15 Flowonix Medical Inc Company Overview 49
    • 5.15.1 Flowonix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 49
  • 5.16 Fluonic, Inc. Company Overview 53
    • 5.16.1 Fluonic, Inc. Pipeline Products & Ongoing Clinical Trials Overview 53
  • 5.17 Fresenius Medical Care AG & Co KGaA Company Overview 54
    • 5.17.1 Fresenius Medical Care AG & Co KGaA Pipeline Products & Ongoing Clinical Trials Overview 54
  • 5.18 Hospira Inc Company Overview 55
    • 5.18.1 Hospira Inc Pipeline Products & Ongoing Clinical Trials Overview 55
  • 5.19 Innovfusion Pte. Ltd. Company Overview 57
    • 5.19.1 Innovfusion Pte. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 57
  • 5.20 Intarcia Therapeutics Inc Company Overview 60
    • 5.20.1 Intarcia Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 60
  • 5.21 IRadimed Corp Company Overview 62
    • 5.21.1 IRadimed Corp Pipeline Products & Ongoing Clinical Trials Overview 62
  • 5.22 Ivenix Inc Company Overview 63
    • 5.22.1 Ivenix Inc Pipeline Products & Ongoing Clinical Trials Overview 63
  • 5.23 LifeMedix, LLC Company Overview 64
    • 5.23.1 LifeMedix, LLC Pipeline Products & Ongoing Clinical Trials Overview 64
  • 5.24 Lynntech Inc Company Overview 65
    • 5.24.1 Lynntech Inc Pipeline Products & Ongoing Clinical Trials Overview 65
  • 5.25 Massachusetts Institute of Technology Company Overview 66
    • 5.25.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 66
  • 5.26 Medallion Therapeutics, Inc. Company Overview 69
    • 5.26.1 Medallion Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 69
  • 5.27 Medical Device Creations Ltd. Company Overview 70
    • 5.27.1 Medical Device Creations Ltd. Pipeline Products & Ongoing Clinical Trials Overview 70
  • 5.28 MedPrime Technologies Pvt. Ltd. Company Overview 71
    • 5.28.1 MedPrime Technologies Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 71
  • 5.29 Medtronic plc Company Overview 72
    • 5.29.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 72
  • 5.30 NexGen Medical Systems Inc Company Overview 74
    • 5.30.1 NexGen Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 74
  • 5.31 Palyon Medical Corp (Inactive) Company Overview 75
    • 5.31.1 Palyon Medical Corp (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 75
  • 5.32 Pavmed Inc Company Overview 76
    • 5.32.1 Pavmed Inc Pipeline Products & Ongoing Clinical Trials Overview 76
  • 5.33 PRO-IV Medical Ltd Company Overview 77
    • 5.33.1 PRO-IV Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 77
  • 5.34 Ratio Inc Company Overview 78
    • 5.34.1 Ratio Inc Pipeline Products & Ongoing Clinical Trials Overview 78
  • 5.35 Rice University Company Overview 79
    • 5.35.1 Rice University Pipeline Products & Ongoing Clinical Trials Overview 79
  • 5.36 scPharmaceuticals Inc Company Overview 80
    • 5.36.1 scPharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 80
  • 5.37 SteadyMed Therapeutics Inc Company Overview 81
    • 5.37.1 SteadyMed Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 81
  • 5.38 StnDrd Infusion Corporation Company Overview 84
    • 5.38.1 StnDrd Infusion Corporation Pipeline Products & Ongoing Clinical Trials Overview 84
  • 5.39 Surefire Medical Inc Company Overview 85
    • 5.39.1 Surefire Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 85
  • 5.40 Tandem Diabetes Care Inc Company Overview 88
    • 5.40.1 Tandem Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview 88
  • 5.41 Terumo Corp Company Overview 89
    • 5.41.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 89
  • 5.42 ToucheMedical Ltd. Company Overview 91
    • 5.42.1 ToucheMedical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 91
  • 5.43 Turnpoint Medical Devices Inc Company Overview 92
    • 5.43.1 Turnpoint Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 92
  • 5.44 Unilife Corporation Company Overview 93
    • 5.44.1 Unilife Corporation Pipeline Products & Ongoing Clinical Trials Overview 93
  • 5.45 University of Minnesota Company Overview 94
    • 5.45.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 94
  • 5.46 University of Southern California Company Overview 95
    • 5.46.1 University of Southern California Pipeline Products & Ongoing Clinical Trials Overview 95
  • 5.47 vTitan Corporation Pvt Ltd Company Overview 96
    • 5.47.1 vTitan Corporation Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 96

6 Infusion Systems- Recent Developments 98

  • 6.1 Mar 09, 2018: Maura Dickler, M.D. To Become Vice President Of Late Phase Development At Lilly Oncology 98
  • 6.2 Mar 07, 2018: Successful inspection increases manufacturing capacity 98
  • 6.3 Mar 06, 2018: Zyno Solutions To Feature Z-800F IV Infusion Pump At MHA Business Summit 99
  • 6.4 Mar 05, 2018: 3M Announces New Leadership Appointments 99
  • 6.5 Mar 03, 2018: Lenstec And Oculentis Settle Legal Dispute Over Patents For Bifocal IOLs 100
  • 6.6 Mar 02, 2018: ICU Medical's Plum 360 Infusion System Receives the Prestigious 2018 Best in KLAS Award 100
  • 6.7 Mar 01, 2018: DURECT Announces Fourth Quarter and Full Year 2017 Financial Results and Update of Programs 101
  • 6.8 Mar 01, 2018: Poly Medicure: Commencement of Commercial Production 103
  • 6.9 Feb 28, 2018: Alimera Sciences Reports Fourth Quarter and Full Year 2017 Financial Results 103
  • 6.10 Feb 28, 2018: Admedus Financial Results For The Period Ended 31 December 2017 105
  • 6.11 Feb 27, 2018: Admedus: Resignation / Appointment of Company Secretary and Change of Registered Office 107
  • 6.12 Feb 26, 2018: Akorn Issues Statement on Investigation 107
  • 6.13 Feb 26, 2018: Fresenius remains on growth course after 14 straight record years 108
  • 6.14 Feb 22, 2018: Teleflex Reports Fourth Quarter and Full Year 2017 Results; Provides 2018 Guidance 114
  • 6.15 Feb 21, 2018: Orthodontists, Oral Surgeons, Periodontists and Other Specialists Introduced to Teledentistry to Increase the Conversion and Ease of Patient Referrals 116
  • 6.16 Feb 21, 2018: Ivenix to Showcase Novel Infusion Delivery System at HIMSS18 117
  • 6.17 Feb 15, 2018: ConvaTec Group Annual Results 2017 117
  • 6.18 Feb 15, 2018: ConvaTec Group Reports Annual Financial Results For 2017 119
  • 6.19 Feb 08, 2018: Cardinal Health Reports Second-quarter Results for Fiscal Year 2018 125
  • 6.20 Feb 08, 2018: Terumo Revises the Full-Year Results Forecast for FY 2017 126
  • 6.21 Feb 08, 2018: Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Highlights Recent Period Activity 127
  • 6.22 Feb 07, 2018: Cardinal Health Adds Akhil Johri to its Board of Directors 130
  • 6.23 Feb 06, 2018: IRADIMED Reports Revenue Of $6.7 Million In The Fourth Quarter Ended December 31, 2017 130
  • 6.24 Feb 06, 2018: Raumedic modernizing German headquarters 132
  • 6.25 Feb 05, 2018: Zyno Solutions Names Steve Watkins As General Manager And Executive Vice President 133
  • 6.26 Feb 01, 2018: Novo Nordisk increased reported operating profit by 1% in 2017 to DKK 49 billion (5% growth in local currencies) 133
  • 6.27 Feb 01, 2018: Baxter Reports 2017 Fourth-Quarter and Full-Year Results 134
  • 6.28 Feb 01, 2018: Edwards Life sciences Reports Fourth Quarter Results 137
  • 6.29 Feb 01, 2018: Cobra Biologics and Symbiosis Awarded £1.9m ($2.5m USD) Innovate UK Grant 138
  • 6.30 Jan 31, 2018: Lilly Reports Strong Fourth-Quarter and Full-Year 2017 Revenue Growth, Increases 2018 EPS Guidance 139
  • 6.31 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region 145
  • 6.32 Jan 30, 2018: Admedus: Quarterly report - Appendix 4C for the period to 31 December 2017. 146
  • 6.33 Jan 29, 2018: Terumo Integrates Two R&D Facilities in Silicon Valley to Accelerate Development of Innovative Medical Devices 148
  • 6.34 Jan 29, 2018: HES solutions should remain on the market 149
  • 6.35 Jan 25, 2018: 3M Reports Fourth-Quarter 2017 Results; Raises 2018 Earnings Outlook 149
  • 6.36 Jan 25, 2018: Terumo Announces Change of Directors and Executive Officers 152
  • 6.37 Jan 23, 2018: Surefire Medical Names Mary T. Szela CEO and President 154
  • 6.38 Jan 22, 2018: IRADIMED Announces 2018 Annual and First Quarter Financial Guidance 155
  • 6.39 Jan 18, 2018: B. Braun to Showcase Comprehensive Parenteral Nutrition Program, New Compounder and More at ASPEN 155
  • 6.40 Jan 18, 2018: Raumedic presents solutions for wearable drug injection devices 156
  • 6.41 Jan 11, 2018: New Study Shows Superiority of Intrathecal Baclofen Therapy Over Oral Medication for the Treatment of Severe Post-Stroke Spasticity 157
  • 6.42 Jan 10, 2018: FDA Approves Innovative Clinician Programmer for the Medtronic SynchroMed II Intrathecal Drug Delivery System for Chronic Pain and Severe Spasticity 158
  • 6.43 Jan 10, 2018: FDA Approves Innovative Clinician Programmer for the Medtronic SynchroMed II Intrathecal Drug Delivery System for Chronic Pain and Severe Spasticity 159
  • 6.44 Jan 08, 2018: MicroPort Life sciences Displayed La Fenice Hypophyseal Hormone Infusion Pump at CDS2017 160
  • 6.45 Jan 04, 2018: AngioDynamics Reports Fiscal 2018 Second Quarter Financial Results 161
  • 6.46 Jan 02, 2018: Teleflex Completes Previously Announced CEO Transition 162

7 Appendix 338

  • 7.1 Methodology 338
  • 7.2 About GlobalData 341
  • 7.3 Contact Us 341
  • 7.4 Disclaimer 341

List of Tables

1.1 List of Tables

  • Table 1: Infusion Systems - Pipeline Products by Stage of Development 16
  • Table 2: Infusion Systems - Pipeline Products by Segment 17
  • Table 3: Infusion Systems - Pipeline Products by Territory 19
  • Table 4: Infusion Systems - Pipeline Products by Regulatory Path 20
  • Table 5: Infusion Systems - Pipeline Products by Estimated Approval Date 21
  • Table 6: Infusion Systems - Ongoing Clinical Trials 22
  • Table 7: Infusion Systems Companies - Pipeline Products by Stage of Development 23
  • Table 8: Infusion Systems - Pipeline Products by Stage of Development 25
  • Table 9: 410 Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 27
  • Table 10: LifeFlow Rapid Infusion Device - Severe Hemorrhage - Product Status 27
  • Table 11: LifeFlow Rapid Infusion Device - Severe Hemorrhage - Product Description 27
  • Table 12: Adept Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 28
  • Table 13: Adept IVO - Product Status 28
  • Table 14: Adept IVO - Product Description 28
  • Table 15: AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 29
  • Table 16: Next Gen Tumescent Delivery Device - Product Status 29
  • Table 17: Next Gen Tumescent Delivery Device - Product Description 29
  • Table 18: Arnali, LLC Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 19: Arnali Michelangelo Robot - Product Status 30
  • Table 20: Arnali Michelangelo Robot - Product Description 30
  • Table 21: Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 22: Infusion Pump - Product Status 31
  • Table 23: Infusion Pump - Product Description 31
  • Table 24: BioQ Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview 32
  • Table 25: Pre-Filled Infusion System - Antibiotics - Product Status 32
  • Table 26: Pre-Filled Infusion System - Antibiotics - Product Description 32
  • Table 27: Pre-Filled Infusion System - Oncology - Product Status 32
  • Table 28: Pre-Filled Infusion System - Oncology - Product Description 33
  • Table 29: Propofol Pre-Filled Infusion System - Product Status 33
  • Table 30: Propofol Pre-Filled Infusion System - Product Description 33
  • Table 31: Ropivacaine ReadyFusOR - Product Status 34
  • Table 32: Ropivacaine ReadyFusOR - Product Description 34
  • Table 33: BioQ Pharma Inc - Ongoing Clinical Trials Overview 35
  • Table 34: Ropivacaine ReadyFusOR - Pilot Healthcare Economics and Observational Study of the Onedose Readyfusor (A Factory-Filled Infusion Device Delivering a Continuous Infusion of Ropivacaine 2mg/Ml For Up To 48 Hours), for the Treatment of Post-operative Pain in Patients Who Have Undergone Open Intra-abdominal Surgery (Laparotomy) 36
  • Table 35: Caesarea Medical Electronics Ltd Pipeline Products & Ongoing Clinical Trials Overview 37
  • Table 36: BodyGuard Quadro - Product Status 37
  • Table 37: BodyGuard Quadro - Product Description 37
  • Table 38: T34-1ml - Product Status 38
  • Table 39: T34-1ml - Product Description 38
  • Table 40: ClearLine MD Pipeline Products & Ongoing Clinical Trials Overview 39
  • Table 41: FloStat Infusion Pump System - Product Status 39
  • Table 42: FloStat Infusion Pump System - Product Description 39
  • Table 43: ConvaTec Group Plc Pipeline Products & Ongoing Clinical Trials Overview 40
  • Table 44: neria Guard Infusion Set - Product Status 40
  • Table 45: neria Guard Infusion Set - Product Description 40
  • Table 46: Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview 41
  • Table 47: MIP Implantable Pump - Product Status 41
  • Table 48: MIP Implantable Pump - Product Description 41
  • Table 49: Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview 42
  • Table 50: Integrated Semi-Closed Loop System - Product Status 42
  • Table 51: Integrated Semi-Closed Loop System - Product Description 42
  • Table 52: Eksigent Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 43
  • Table 53: External Drug Delivery System - Product Status 43
  • Table 54: External Drug Delivery System - Product Description 43
  • Table 55: Implantable Drug Delivery System - Product Status 43
  • Table 56: Implantable Drug Delivery System - Product Description 44
  • Table 57: Eli Lilly and Co Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 58: Drug Delivery System - Parkinson's Disease - Product Status 45
  • Table 59: Drug Delivery System - Parkinson's Disease - Product Description 45
  • Table 60: EryDel SPA Pipeline Products & Ongoing Clinical Trials Overview 46
  • Table 61: EryDex System - Product Status 46
  • Table 62: EryDex System - Product Description 46
  • Table 63: EryDel SPA - Ongoing Clinical Trials Overview 47
  • Table 64: EryDex System - Multi-center, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Effects of Intra-erythrocyte Dexamethasone Sodium Phosphate on Neurological Symptoms in Patients with Ataxia Telangiectasia 48
  • Table 65: Flowonix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 49
  • Table 66: Implanted Drug Delivery System - Product Status 49
  • Table 67: Implanted Drug Delivery System - Product Description 49
  • Table 68: Prometra II Programmable Infusion System - ICV - Product Status 50
  • Table 69: Prometra II Programmable Infusion System - ICV - Product Description 50
  • Table 70: Flowonix Medical Inc - Ongoing Clinical Trials Overview 51
  • Table 71: Prometra II Programmable Infusion System - ICV - A Dose Ranging Pilot Study to Assess Intracerebroventricular (ICV) Delivery of Valproate in Subjects with Focal Seizures, with Temporal Lobe Onset with or without Secondary Generalization 52
  • Table 72: Fluonic, Inc. Pipeline Products & Ongoing Clinical Trials Overview 53
  • Table 73: SURE+ - Product Status 53
  • Table 74: SURE+ - Product Description 53
  • Table 75: Fresenius Medical Care AG & Co KGaA Pipeline Products & Ongoing Clinical Trials Overview 54
  • Table 76: Intravenous 2008MeDS - Product Status 54
  • Table 77: Intravenous 2008MeDS - Product Description 54
  • Table 78: Hospira Inc Pipeline Products & Ongoing Clinical Trials Overview 55
  • Table 79: Lifecare PCA Restart - Product Status 55
  • Table 80: Lifecare PCA Restart - Product Description 55
  • Table 81: Smart Infusion Pump Integrated With Accelero Connect Software - Product Status 56
  • Table 82: Smart Infusion Pump Integrated With Accelero Connect Software - Product Description 56
  • Table 83: Innovfusion Pte. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 57
  • Table 84: DIVA - Product Status 57
  • Table 85: DIVA - Product Description 57
  • Table 86: EPIVA - Product Status 58
  • Table 87: EPIVA - Product Description 58
  • Table 88: INTRAVA - Product Status 58
  • Table 89: INTRAVA - Product Description 59
  • Table 90: Intarcia Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 60
  • Table 91: ITCA 650 Osmotic Pump - Product Status 60
  • Table 92: ITCA 650 Osmotic Pump - Product Description 60
  • Table 93: Omega DUROS - Product Status 61
  • Table 94: Omega DUROS - Product Description 61
  • Table 95: IRadimed Corp Pipeline Products & Ongoing Clinical Trials Overview 62
  • Table 96: Next-generation MRI IV Pump - Product Status 62
  • Table 97: Next-generation MRI IV Pump - Product Description 62
  • Table 98: Ivenix Inc Pipeline Products & Ongoing Clinical Trials Overview 63
  • Table 99: Ivenix Infusion System - Product Status 63
  • Table 100: Ivenix Infusion System - Product Description 63
  • Table 101: LifeMedix, LLC Pipeline Products & Ongoing Clinical Trials Overview 64
  • Table 102: STATfusion - Product Status 64
  • Table 103: STATfusion - Product Description 64
  • Table 104: Lynntech Inc Pipeline Products & Ongoing Clinical Trials Overview 65
  • Table 105: Disposable Drug Infusion Pump - Product Status 65
  • Table 106: Disposable Drug Infusion Pump - Product Description 65
  • Table 107: Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 66
  • Table 108: Compact Self-Powered Actuator - Product Status 66
  • Table 109: Compact Self-Powered Actuator - Product Description 66
  • Table 110: Implantable Micro - Cannula Device - Product Status 67
  • Table 111: Implantable Micro - Cannula Device - Product Description 67
  • Table 112: MiNDS - Product Status 67
  • Table 113: MiNDS - Product Description 68
  • Table 114: Medallion Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 69
  • Table 115: Medallion Infusion Pump System - Product Status 69
  • Table 116: Medallion Infusion Pump System - Product Description 69
  • Table 117: Medical Device Creations Ltd. Pipeline Products & Ongoing Clinical Trials Overview 70
  • Table 118: Infusion Pump - Product Status 70
  • Table 119: Infusion Pump - Product Description 70
  • Table 120: MedPrime Technologies Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 71
  • Table 121: InfuCheck - Product Status 71
  • Table 122: InfuCheck - Product Description 71
  • Table 123: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 72
  • Table 124: ALN-HTT Infusion System - Product Status 72
  • Table 125: ALN-HTT Infusion System - Product Description 72
  • Table 126: SynchroMed II+ - Product Status 73
  • Table 127: SynchroMed II+ - Product Description 73
  • Table 128: NexGen Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 74
  • Table 129: PeriCATH - Product Status 74
  • Table 130: PeriCATH - Product Description 74
  • Table 131: Palyon Medical Corp (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 75
  • Table 132: Palyon Implantable Drug Delivery System - Product Status 75
  • Table 133: Palyon Implantable Drug Delivery System - Product Description 75
  • Table 134: Pavmed Inc Pipeline Products & Ongoing Clinical Trials Overview 76
  • Table 135: NextFlo - Product Status 76
  • Table 136: NextFlo - Product Description 76
  • Table 137: PRO-IV Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 77
  • Table 138: IMMAGES - Product Status 77
  • Table 139: IMMAGES - Product Description 77
  • Table 140: Ratio Inc Pipeline Products & Ongoing Clinical Trials Overview 78
  • Table 141: NuPrivo - CI - Product Status 78
  • Table 142: NuPrivo - CI - Product Description 78
  • Table 143: Rice University Pipeline Products & Ongoing Clinical Trials Overview 79
  • Table 144: AutoSyP Syringe Pump - Product Status 79
  • Table 145: AutoSyP Syringe Pump - Product Description 79
  • Table 146: scPharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 80
  • Table 147: sc2Wear Furosemide Infusor - Product Status 80
  • Table 148: sc2Wear Furosemide Infusor - Product Description 80
  • Table 149: SteadyMed Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 81
  • Table 150: PatchPump - SMT-201 - Product Status 81
  • Table 151: PatchPump - SMT-201 - Product Description 81
  • Table 152: PatchPump - SMT-301 - Product Status 82
  • Table 153: PatchPump - SMT-301 - Product Description 82
  • Table 154: Trevyent - Product Status 82
  • Table 155: Trevyent - Product Description 83
  • Table 156: StnDrd Infusion Corporation Pipeline Products & Ongoing Clinical Trials Overview 84
  • Table 157: StnDrd Infusion Pump - Product Status 84
  • Table 158: StnDrd Infusion Pump - Product Description 84
  • Table 159: Surefire Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 85
  • Table 160: Surefire Precision Infusion System - Hepatocellular Carcinoma - Product Status 85
  • Table 161: Surefire Precision Infusion System - Hepatocellular Carcinoma - Product Description 85
  • Table 162: Surefire Medical Inc - Ongoing Clinical Trials Overview 86
  • Table 163: Surefire Precision Infusion System - Hepatocellular Carcinoma - SPEED 1 Trial: Bridge to Orthotopic Liver Transplantation (OLT) - (Surefire Precision Versus Endhole Embolization with DEBTACE) 87
  • Table 164: Surefire Precision Infusion System - Hepatocellular Carcinoma - Surefire Precision Infusion System Registry 87
  • Table 165: Surefire Precision Infusion System - Hepatocellular Carcinoma - Surefire Versus Endhole for DEB-TACE: Quantifying Hepatic Artery Embolization to Improve Outcomes by Comparing Two Different Catheter Systems for DEB-TACE (QED Study) 87
  • Table 166: Tandem Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview 88
  • Table 167: AutoSoft XC - Product Status 88
  • Table 168: AutoSoft XC - Product Description 88
  • Table 169: Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 89
  • Table 170: Next Generation SmartPump - Product Status 89
  • Table 171: Next Generation SmartPump - Product Description 89
  • Table 172: Vertical Infusion Pump - Product Status 90
  • Table 173: Vertical Infusion Pump - Product Description 90
  • Table 174: ToucheMedical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 91
  • Table 175: Syringe Based Patch Pump - Product Status 91
  • Table 176: Syringe Based Patch Pump - Product Description 91
  • Table 177: Turnpoint Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 92
  • Table 178: Breeze Infusion Pump - Product Status 92
  • Table 179: Breeze Infusion Pump - Product Description 92
  • Table 180: Unilife Corporation Pipeline Products & Ongoing Clinical Trials Overview 93
  • Table 181: Unilife AutoInfusor - Product Status 93
  • Table 182: Unilife AutoInfusor - Product Description 93
  • Table 183: University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 94
  • Table 184: Infusion Micropump - Product Status 94
  • Table 185: Infusion Micropump - Product Description 94
  • Table 186: University of Southern California Pipeline Products & Ongoing Clinical Trials Overview 95
  • Table 187: Drug Infusion Pump - Product Status 95
  • Table 188: Drug Infusion Pump - Product Description 95
  • Table 189: vTitan Corporation Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 96
  • Table 190: AccuFlow IBP-550 Syringe Pump - Product Status 96
  • Table 191: AccuFlow IBP-550 Syringe Pump - Product Description 96
  • Table 192: AccuFlow SP-550 Syringe Pump - Product Status 97
  • Table 193: AccuFlow SP-550 Syringe Pump - Product Description 97
  • Table 194: Glossary 340

List of Figures

1.2 List of Figures

  • Figure 1: Infusion Systems - Pipeline Products by Stage of Development 16
  • Figure 2: Infusion Systems - Pipeline Products by Segment 17
  • Figure 3: Infusion Systems - Pipeline Products by Territory 18
  • Figure 4: Infusion Systems - Pipeline Products by Regulatory Path 20
  • Figure 5: Infusion Systems - Pipeline Products by Estimated Approval Date 21
  • Figure 6: Infusion Systems - Ongoing Clinical Trials 22
Back to Top